Uscom Limited (ASX:UCM)

Market Cap	3.12M -77.5%
Revenue (ttm)	2.58M -30.8%
Net Income	-3.30M
EPS	-0.02
Shares Out	260.15M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5,000
Average Volume	178,515
Open	0.0120
Previous Close	0.0120
Day's Range	0.0120 - 0.0120
52-Week Range	0.0110 - 0.0450
Beta	-1.54
RSI	39.90
Earnings Date	Feb 24, 2026

About Uscom

Uscom Limited designs, develops, manufactures, and markets non-invasive cardiovascular and pulmonary medical devices in Australia, Asia, the Americas, and Europe. It offers USCOM 1A, a non-invasive hemodynamic monitor that measures blood flow, stroke volume, and cardiac output; and BP+, a supra-systolic oscillometric central blood pressure monitor that measures blood pressure and blood pressure waveforms at the heart, as well as in the arm. The company also provides the SpiroSonic Ultrasonic spirometer, a pulmonary function testing device that ...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1999
• Employees: 35
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: UCM

Financial Performance

In fiscal year 2025, Uscom's revenue was 2.58 million, a decrease of -30.80% compared to the previous year's 3.73 million. Losses were -3.30 million, 59.2% more than in 2024.